1. topiramate -- score = 3.33785842904
	topiramate treatment -- 6
	topiramate group -- 3
	topiramate users -- 3
	topiramate withdrawal -- 2
	low-dose topiramate -- 2
	topiramate therapy -- 2
	comprehensive topiramate database review -- 1
	prophylactic topiramate treatment -- 1
	topiramate groups -- 1
	topiramate double-blind -- 1
2. prophylaxis -- score = 3.33785842904
	migraine prophylaxis -- 29
	medical prophylaxis -- 5
	research evaluating migraine prophylaxis therapy -- 2
	chronic migraine prophylaxis -- 2
	headache prophylaxis -- 2
	pharmacological prophylaxis -- 2
	successful prophylaxis -- 1
	topiramate migraine prophylaxis -- 1
	aspirin prophylaxis -- 1
	treatment prophylaxis -- 1
3. migraine -- score = 3.33785842904
	migraine patients -- 213
	chronic migraine -- 198
	migraine attacks -- 117
	migraine headache -- 87
	episodic migraine -- 77
	vestibular migraine -- 63
	migraine headaches -- 41
	migraine attack -- 31
	migraine prophylaxis -- 29
	migraine pain -- 28
4. headache -- score = 3.17868923978
	migraine headache -- 87
	tension-type headache -- 86
	headache disorders -- 57
	cluster headache -- 52
	headache frequency -- 51
	migraine headaches -- 41
	primary headaches -- 40
	headache days -- 33
	chronic headache -- 30
	primary headache -- 29
5. patients -- score = 2.91645394855
	migraine patients -- 213
	patients -- 65
	chronic migraine patients -- 17
	pediatric patients -- 16
	aura patients -- 16
	consecutive patients -- 13
	many patients -- 10
	adult patients -- 9
	tinnitus patients -- 7
	mwoa patients -- 7
6. studies -- score = 2.90902085421
	further studies -- 24
	future studies -- 17
	clinical studies -- 15
	several studies -- 12
	few studies -- 12
	previous studies -- 10
	experimental studies -- 7
	controlled studies -- 7
	recent studies -- 7
	STUDY DESIGN -- 6
7. pain -- score = 2.82865989654
	pain intensity -- 30
	migraine pain -- 28
	chronic pain -- 27
	neck pain -- 19
	abdominal pain -- 17
	pain relief -- 13
	neuropathic pain -- 13
	pain modulation -- 10
	facial pain -- 9
	migraine pain intensity -- 8
8. treatment -- score = 2.80277372529
	acute treatment -- 27
	preventive treatment -- 25
	prophylactic treatment -- 23
	migraine treatment -- 22
	acute migraine treatment -- 12
	effective treatment -- 12
	treatment options -- 11
	treatment group -- 8
	topiramate treatment -- 6
	medical treatment -- 6
9. clinical -- score = 2.74115159885
	clinical features -- 43
	clinical trials -- 41
	clinical characteristics -- 27
	clinical trial -- 20
	clinical data -- 16
	clinical studies -- 15
	clinical practice -- 11
	clinical outcomes -- 8
	clinical diagnosis -- 8
	headache clinic -- 6
10. groups -- score = 2.71432975975
	migraine groups -- 8
	control groups -- 7
	patient groups -- 6
	groups -- 6
	age groups -- 5
	treatment groups -- 4
	other groups -- 4
	placebo groups -- 3
	chronic migraine groups -- 2
	metoclopramide groups -- 2
11. chronic -- score = 2.69810054562
	chronic migraine -- 198
	chronic headache -- 30
	chronic pain -- 27
	chronic conditions -- 21
	chronic migraine patients -- 17
	chronic headaches -- 15
	chronic kidney disease -- 7
	chronic diseases -- 7
	chronic migraines -- 6
	chronic migraineurs -- 5
12. disorders -- score = 2.67302090713
	headache disorders -- 57
	neurological disorders -- 34
	gastrointestinal disorders -- 16
	primary headache disorders -- 16
	bipolar disorder -- 14
	vestibular disorders -- 12
	neurological disorder -- 12
	mood disorders -- 11
	temporomandibular disorders -- 9
	affective disorders -- 8
13. attacks -- score = 2.64345267649
	migraine attacks -- 117
	migraine attack -- 31
	ischemic attacks -- 15
	headache attacks -- 14
	attack frequency -- 14
	spontaneous migraine attacks -- 11
	acute migraine attacks -- 9
	attack duration -- 7
	headache attack -- 7
	migraine-like attacks -- 7
14. disease -- score = 2.52504480704
	cardiovascular disease -- 15
	neurological diseases -- 10
	sickle cell disease -- 8
	cerebrovascular disease -- 8
	chronic kidney disease -- 7
	disease duration -- 7
	chronic diseases -- 7
	coronary artery disease -- 6
	disease severity -- 6
	small vessel disease -- 5
15. medication -- score = 2.49831055379
	medication overuse -- 19
	medication overuse headache -- 17
	medical history -- 13
	preventive medications -- 7
	medical treatment -- 6
	medical students -- 6
	medication use -- 6
	rescue medication -- 6
	medical literature -- 5
	medical prophylaxis -- 5
16. effects -- score = 2.48287358361
	side effects -- 14
	adverse effects -- 12
	effective treatment -- 12
	analgesic effect -- 6
	main effect -- 5
	cardiovascular effects -- 4
	main effects -- 4
	significant effect -- 4
	effective treatments -- 4
	synergistic effects -- 4
17. control -- score = 2.47567118832
	healthy controls -- 69
	control group -- 58
	controlled trials -- 10
	control subjects -- 9
	control groups -- 7
	controlled trial -- 7
	normal controls -- 7
	controlled studies -- 7
	healthy control subjects -- 6
	inhibitory control -- 6
18. difference -- score = 2.45788189673
	significant difference -- 35
	different types -- 7
	mean difference -- 6
	different regions -- 5
	different doses -- 4
	different factors -- 2
	different stimuli -- 2
	statistical difference -- 2
	different treatments -- 2
	different phases -- 2
19. symptoms -- score = 2.43933269383
	migraine symptoms -- 17
	neurological symptoms -- 10
	vestibular symptoms -- 9
	premonitory symptoms -- 9
	headache symptoms -- 8
	autonomic symptoms -- 6
	clinical symptoms -- 6
	common symptom -- 5
	depression symptoms -- 4
	pre-attack symptoms -- 4
20. activation -- score = 2.41995574849
	physical activity -- 10
	trigeminovascular activation -- 9
	daily activities -- 9
	trigeminal activation -- 7
	analgesic activity -- 6
	active compounds -- 5
	neuronal activity -- 4
	cortical serotonergic activity -- 3
	inos activity -- 3
	disease activity -- 3
21. significant -- score = 2.40993312333
	significant difference -- 35
	significant differences -- 33
	significant association -- 15
	significant improvement -- 15
	significant reduction -- 13
	significant increase -- 8
	significant decrease -- 7
	significant impact -- 5
	significant effect -- 4
	significant disability -- 4
22. functional -- score = 2.39967372148
	functional connectivity -- 28
	functional changes -- 6
	functional disorders -- 4
	physiological functions -- 4
	functional level -- 4
	functional gastrointestinal disorders -- 4
	physical functioning -- 4
	functional dyspepsia -- 4
	functional role -- 3
	functional connections -- 3
23. factors -- score = 2.38738982634
	risk factors -- 28
	risk factor -- 16
	familial factors -- 7
	reproductive risk factors -- 7
	psychological factors -- 6
	environmental factors -- 6
	vascular risk factors -- 6
	social factors -- 5
	factor -- 3
	demographic factors -- 3
24. brain -- score = 2.38381536598
	traumatic brain injury -- 16
	brain regions -- 8
	brain structure -- 7
	deep brain nuclei -- 5
	brain MRI -- 5
	migraine brain -- 5
	brain magnetic resonance imaging -- 5
	hum brain mapp -- 5
	brain oxidative stress -- 4
	whole brain -- 4
25. primary -- score = 2.36172783602
	primary headaches -- 40
	primary headache -- 29
	primary headache disorders -- 16
	primary outcome -- 11
	primary care -- 11
	primary endpoint -- 10
	primary headache disorder -- 8
	primary outcome measure -- 7
	primary afferents -- 4
	primary dysmenorrhoea -- 4
26. system -- score = 2.35024801833
	nervous system -- 27
	trigeminovascular system -- 23
	trigeminal system -- 9
	visual system -- 7
	systemic administration -- 5
	delivery system -- 4
	cardiovascular system -- 4
	systemic inflammation -- 3
	systemic diseases -- 3
	endocannabinoid system -- 3
27. models -- score = 2.33645973385
	experimental models -- 7
	animal models -- 7
	linear regression models -- 4
	logistic regression models -- 3
	human models -- 3
	linear models -- 3
	preclinical models -- 2
	predictive animal models -- 2
	mixed models -- 2
	mouse models -- 2
28. several -- score = 2.33041377335
	headache severity -- 18
	several studies -- 12
	migraine severity -- 11
	pain severity -- 7
	severe headache -- 7
	disease severity -- 6
	severe headache days -- 5
	insomnia severity index -- 3
	TMD severity -- 3
	migraine headache severity -- 3
29. receptor -- score = 2.32837960344
	CGRP receptor -- 13
	opioid receptors -- 7
	CGRP receptors -- 7
	5-HT1B receptor binding -- 5
	receptor-like receptor -- 4
	transient receptor potential -- 4
	related receptors -- 3
	CGRP receptor antagonists -- 3
	TRPA1 receptors -- 3
	receptor activity-modifying protein -- 3
30. risk -- score = 2.31806333496
	risk factors -- 28
	risk factor -- 16
	reproductive risk factors -- 7
	health risk behaviors -- 6
	ovarian cancer risk -- 6
	vascular risk factors -- 6
	migraine risk -- 5
	increased risk -- 5
	relative risk -- 4
	risk ratio -- 4
31. therapies -- score = 2.29446622616
	behavioral therapy -- 9
	prophylactic therapy -- 8
	therapy -- 7
	preventive therapy -- 6
	migraine therapy -- 5
	radiation therapy syndrome -- 4
	manipulative therapy -- 4
	radiation therapy -- 4
	acute migraine therapy -- 4
	occupational therapy -- 3
32. mechanical -- score = 2.29446622616
	pathophysiological mechanisms -- 11
	underlying mechanisms -- 7
	mechanical stimuli -- 5
	mechanical allodynia -- 5
	possible mechanism -- 4
	biological mechanisms -- 4
	neurovascular mechanisms -- 3
	cholinergic mechanisms -- 3
	pathogenesis-related mechanisms -- 3
	mechanical threshold -- 3
33. ANALYSIS -- score = 2.28103336725
	DATA COLLECTION AND ANALYSIS -- 2
34. trigeminal -- score = 2.27646180417
	trigeminal nucleus caudalis -- 22
	trigeminal ganglia -- 19
	trigeminal ganglion -- 15
	trigeminal system -- 9
	trigeminal neurons -- 7
	trigeminal activation -- 7
	trigeminal neuralgia -- 5
	trigeminal area -- 5
	trigeminal nucleus -- 5
	trigeminal pain -- 4
35. levels -- score = 2.27646180417
	serum levels -- 7
	CGRP levels -- 7
	plasma levels -- 6
	levels -- 4
	high levels -- 4
	l-arginine levels -- 3
	peripheral CGRP levels -- 3
	pain levels -- 3
	leptin levels -- 3
	homocysteine levels -- 2
36. episodes -- score = 2.27415784926
	episodic migraine -- 77
	recurrent episodes -- 7
	episodic migraineurs -- 6
	migraine episodes -- 5
	episodic migraine patients -- 4
	first episode -- 4
	episodic migraines -- 4
	episodic headache -- 3
	episodic tension type headache -- 3
	episodic symptoms -- 2
37. trial -- score = 2.2671717284
	clinical trials -- 41
	clinical trial -- 20
	controlled trials -- 10
	TRIAL REGISTRATION -- 7
	controlled trial -- 7
	phase III trials -- 3
	placebo-controlled trial -- 3
	randomized controlled trial -- 2
	trial registration -- 2
	idiopathic intracranial hypertension treatment trial -- 2
38. neurological -- score = 2.2671717284
	neurological disorders -- 34
	neurological disorder -- 12
	neurological diseases -- 10
	neurological symptoms -- 10
	neurological examination -- 8
	neurological condition -- 6
	neurological conditions -- 5
	neurological deficit -- 5
	neurological disease -- 5
	neurological signs -- 4
39. DATA -- score = 2.26481782301
	DATA COLLECTION AND ANALYSIS -- 2
40. others -- score = 2.26007138799
	others HIV patients -- 1
	whereas others -- 1
	many others -- 1
41. health -- score = 2.25767857487
	physical health conditions -- 7
	health risk behaviors -- 6
	self-rated health -- 5
	national health -- 5
	health study -- 4
	health care -- 4
	national health insurance research database -- 4
	adult health -- 4
	mental health -- 4
	mental health constructs -- 3
42. visual -- score = 2.24797326636
	visual aura -- 18
	visual cortex -- 12
	visual stimulation -- 11
	visual analogue scale -- 10
	visual vertical -- 8
	visual snow -- 7
	visual system -- 7
	visual problems -- 6
	visual auras -- 5
	visual field -- 5
43. means -- score = 2.24303804869
	therapeutic means -- 1
	double meaning -- 1
	essential meaning -- 1
44. conditions -- score = 2.24303804869
	chronic conditions -- 21
	comorbid conditions -- 8
	pain conditions -- 8
	physical health conditions -- 7
	neurological conditions -- 5
	medical conditions -- 5
	common conditions -- 4
	other conditions -- 4
	chronic pain conditions -- 3
	conditioned pain modulation -- 3
45. drug -- score = 2.24303804869
	drug administration -- 12
	anti-inflammatory drugs -- 6
	anti-migraine drugs -- 6
	prophylactic drugs -- 4
	antiepileptic drug -- 4
	drug development -- 3
	antiepileptic drugs -- 3
	overuse drug -- 3
	drug treatment -- 3
	over-the-counter drugs -- 2
46. neurons -- score = 2.24303804869
	neurons -- 17
	sensory neurons -- 8
	trigeminal neurons -- 7
	trigeminovascular neurons -- 7
	vc/c1 neurons -- 6
	neuronal activity -- 4
	trigeminal ganglion neurons -- 4
	afferent neurons -- 4
	trigeminocervical neurons -- 3
	neuronal excitability -- 3
47. stimulation -- score = 2.24054924828
	visual stimulation -- 11
	current stimulation -- 9
	occipital nerve stimulation -- 8
	magnetic stimulation -- 8
	non-invasive vagus nerve stimulation -- 7
	electrical stimulation -- 7
	sham stimulation -- 6
	dural stimulation -- 5
	supraorbital nerve stimulation -- 4
	noxious stimulation -- 4
48. acute -- score = 2.23804610313
	acute treatment -- 27
	acute migraine -- 19
	acute migraine treatment -- 12
	acute migraine attacks -- 9
	acute migraine headache -- 8
	acute attack treatment -- 4
	acute medication -- 4
	acute migraine therapy -- 4
	acute attacks -- 3
	acute migraine medication -- 2
49. scores -- score = 2.22271647115
	VAS scores -- 6
	subscale scores -- 5
	depression scores -- 5
	pain scores -- 4
	anxiety scores -- 3
	domain scores -- 2
	high depression scores -- 2
	visual analogue scale scores -- 2
	HADS scores -- 2
	CPM scores -- 1
50. testing -- score = 2.22010808804
	genetic testing -- 4
	medical tests -- 3
	vestibular testing -- 2
	diagnostic tests -- 2
	cognitive testing -- 2
	chi-square tests -- 2
	equivalence testing -- 1
	paraclincal tests -- 1
	neuropsychological tests -- 1
	positional nystagmus tests -- 1
51. vestibular -- score = 2.22010808804
	vestibular migraine -- 63
	vestibular disorders -- 12
	vestibular symptoms -- 9
	vestibular rehabilitation -- 8
	vestibular migraine patients -- 6
	vestibular neuritis -- 4
	vestibular migraine subjects -- 4
	vestibular dysfunction -- 4
	vestibular disease patients -- 3
	vestibular testing -- 2
52. syndrome -- score = 2.20951501454
	irritable bowel syndrome -- 16
	legs syndrome -- 12
	cerebral vasoconstriction syndrome -- 6
	SMART syndrome -- 6
	radiation therapy syndrome -- 4
	antiphospholipid syndrome -- 4
	pseudodepression syndrome -- 3
	meridian syndrome -- 3
	facial pain syndromes -- 3
	cyclic vomiting syndrome -- 3
53. frequency -- score = 2.18752072084
	headache frequency -- 51
	migraine frequency -- 17
	attack frequency -- 14
	high frequency -- 5
	migraine attack frequency -- 3
	headache-day frequency non-responders -- 3
	genotype frequencies -- 3
	spatial frequency -- 3
	headache-day frequency -- 3
	headache day frequency -- 2
54. potential -- score = 2.18752072084
	potential role -- 6
	evoked potentials -- 6
	transient receptor potential -- 4
	potential treatment -- 4
	potential migraine biomarkers -- 3
	potential predictors -- 3
	potential mechanism -- 3
	potential mechanisms -- 3
	potential contribution -- 3
	potential association -- 3
55. change -- score = 2.18752072084
	functional changes -- 6
	MRI changes -- 5
	change -- 4
	status change -- 4
	significant change -- 3
	vascular changes -- 3
	weather changes -- 3
	behavioral changes -- 3
	significant changes -- 3
	volumetric brain changes -- 3
56. responses -- score = 2.18184358794
	vasopressor responses -- 3
	neuronal responses -- 3
	affect responses -- 2
	potential responses -- 2
	tachycardic responses -- 2
	photic responses -- 2
	mechanical responses -- 1
	neurogenic motor responses -- 1
	oxytocin inhibits responses -- 1
	caloric responses -- 1
57. reviewers -- score = 2.17609125906
	PURPOSE REVIEW -- 21
	systematic reviews -- 4
	physician reviewers -- 1
	reviewed papers -- 1
	recent reviews -- 1
	retrospective case reviews -- 1
	independent reviewers -- 1
	reviewed abstracts -- 1
58. outcomes -- score = 2.17318626841
	clinical outcomes -- 8
	secondary outcomes -- 5
	main outcomes -- 5
	occupational outcomes -- 3
	MAIN OUTCOME MEASURES -- 3
	unwanted outcomes -- 2
	headache outcomes -- 2
	poor outcomes -- 2
	primary outcomes -- 2
	functional outcomes -- 2
59. populations -- score = 2.17026171539
	general population -- 43
	study population -- 6
	population -- 5
	kuwaiti population -- 4
	pediatric population -- 3
	patient populations -- 3
	indian population -- 2
	patient population -- 2
	entire population -- 2
	study populations -- 2
60. days -- score = 2.16435285578
	headache days -- 33
	migraine days -- 20
	monthly migraine days -- 9
	severe headache days -- 5
	consecutive days -- 4
	monthly headache days -- 4
	medication days -- 4
	headache-free days -- 4
	study day -- 4
	days -- 4
61. diagnosis -- score = 2.1583624921
	differential diagnosis -- 23
	headache diagnosis -- 8
	clinical diagnosis -- 8
	migraine diagnosis -- 6
	correct diagnosis -- 5
	diagnosis -- 5
	final diagnosis -- 4
	accurate diagnosis -- 4
	headache diagnosis type -- 3
	diagnosis type -- 3
62. types -- score = 2.15533603747
	other types -- 10
	different types -- 7
	various types -- 7
	headache types -- 5
	generalised seizure types -- 4
	seizure types -- 3
	common types -- 2
	disease types -- 2
	synoptic air mass types -- 1
	frequent recurrent headache types -- 1
63. healthy -- score = 2.14301480025
	healthy controls -- 69
	healthy subjects -- 19
	healthy volunteers -- 13
	healthy control subjects -- 6
	healthy individuals -- 6
	healthy control group -- 3
	healthy group -- 2
	healthy women -- 2
	healthy children -- 2
	healthy participants -- 2
64. nerves -- score = 2.13672056716
	occipital nerve stimulation -- 8
	non-invasive vagus nerve stimulation -- 7
	supraorbital nerve stimulation -- 4
	occipital nerve block -- 4
	transcutaneous nerve stimulation -- 4
	retinal nerve fiber layer -- 3
	trigeminal nerves -- 3
	retinal nerve fibre layer -- 3
	trigeminal nerve -- 3
	electrical nerve stimulation -- 3
65. aura -- score = 2.13353890837
	migraine aura -- 28
	visual aura -- 18
	aura patients -- 16
	aura attacks -- 6
	typical aura -- 5
	visual auras -- 5
	aura group -- 5
	sensory auras -- 4
	aura symptoms -- 3
	migrainous auras -- 3
66. age -- score = 2.13353890837
	mean age -- 58
	age group -- 14
	median age -- 8
	average age -- 7
	age groups -- 5
	gestational age -- 4
	reproductive age -- 3
	age range -- 3
	attained age -- 2
	development age spectrum -- 1
67. preventive -- score = 2.12710479836
	preventive treatment -- 25
	migraine prevention -- 23
	preventive medications -- 7
	preventive therapy -- 6
	migraine preventives -- 4
	preventive treatments -- 3
	prevention study -- 3
	preventative therapy -- 3
	preventive medication -- 2
	preventive measures -- 2
68. used -- score = 2.12710479836
	useful tool -- 3
	used medication -- 2
	used models -- 1
	migraine-associated allodynia using oral suspension diclofenac -- 1
	method using questionnaires -- 1
	useful input -- 1
	using electrophysiology -- 1
	using trigeminal heat stimulation -- 1
	additional information useful -- 1
	useful headache treatments -- 1
69. common -- score = 2.12057393121
	common causes -- 6
	common type -- 5
	common symptom -- 5
	common conditions -- 4
	common complaint -- 4
	common cause -- 4
	common disorder -- 3
	common complaints -- 3
	common symptoms -- 3
	common variants -- 3
70. CRITERIA -- score = 2.11727129566
	SELECTION CRITERIA -- 2
71. cells -- score = 2.10720996965
	mast cells -- 11
	sickle cell disease -- 8
	MDA-MB-231 cells -- 6
	endothelial cells -- 4
	dural mast cells -- 4
	positive cells -- 3
	glial cells -- 3
	ganglion cell layer -- 3
	smooth muscle cells -- 2
	cell cycle -- 2
72. high -- score = 2.10720996965
	high prevalence -- 14
	high school students -- 8
	high FRS -- 5
	high frequency -- 5
	high sensitivity -- 5
	high levels -- 4
	high risk -- 3
	high rate -- 3
	high level -- 3
	high efficacy -- 2
73. rating -- score = 2.09342168516
	heart rate -- 8
	positive rate -- 5
	age-standardised rates -- 4
	flow rate -- 4
	responder rates -- 3
	age-standardised YLD rates -- 3
	heart rate variability -- 3
	high rate -- 3
	responder rate -- 3
	glomerular filtration rate -- 2
74. cases -- score = 2.08990511144
	cases -- 6
	CASE REPORT -- 3
	CASE PRESENTATION -- 3
	many cases -- 3
	migraine cases -- 2
	clinical cases -- 2
	pediatric cases -- 2
	CASE DESCRIPTION -- 2
	incident cases -- 2
	such cases -- 2
75. evidences -- score = 2.08635983067
	limited efficacy evidences -- 1
	oxidative stress evident -- 1
	additional evidences -- 1
	up-to-date evidences -- 1
	CLINICAL QUESTION/LEVEL EVIDENCE -- 1
	EVIDENCE ACQUISITION -- 1
76. features -- score = 2.08278537032
	clinical features -- 43
	headache features -- 3
	migraine features -- 3
	location features -- 2
	typical features -- 2
	characteristic features -- 2
	unique features -- 2
	asthma features -- 2
	associated features -- 2
	migrainous features -- 2
77. currents -- score = 2.08278537032
	potassium currents -- 2
	nahs-induced currents -- 1
	capsaicin-induced currents -- 1
	inward currents -- 1
	TRESK currents -- 1
78. associated -- score = 2.07554696139
	significant associations -- 4
	allodynia associated -- 2
	associated factors -- 2
	associated features -- 2
	associated variants -- 1
	associated factor -- 1
	multivariate associations -- 1
	pairwise associations -- 1
	extensive associations -- 1
	clinical associations -- 1
79. events -- score = 2.07554696139
	adverse events -- 59
	neurological events -- 2
	ischaemic events -- 2
	oxidative events -- 2
	ischemic events -- 2
	social events -- 2
	future events -- 2
	vascular events -- 2
	stressful events -- 2
	multiphasic events -- 1
80. gene -- score = 2.07554696139
	gene expression -- 9
	CACNA1E gene -- 6
	calcitonin gene -- 4
	NEMP genes -- 4
	ATP1A2 gene -- 4
	FMR1 gene -- 3
	CACNA1A gene -- 3
	gene polymorphism association studies -- 3
	gene polymorphisms -- 3
81. sleep -- score = 2.06818586175
	sleep quality -- 16
	insufficient sleep -- 8
	sleep disturbance -- 8
	sleep duration -- 7
	sleep disturbances -- 7
	sleep problems -- 6
	short sleep duration -- 5
	sleep disorders -- 3
	unhealthy sleep -- 3
	pittsburgh sleep quality index -- 3
82. disability -- score = 2.06818586175
	headache-related disability -- 20
	migraine-related disability -- 13
	migraine disability assessment -- 8
	headache disability -- 7
	migraine disability assessment scale -- 5
	disability worldwide -- 5
	headache disability inventory -- 4
	significant disability -- 4
	neck disability -- 3
	long-term disability -- 3
83. comorbid -- score = 2.06445798923
	psychiatric comorbidities -- 12
	comorbid -- 9
	comorbid conditions -- 8
	comorbid headaches -- 7
	additional comorbidities -- 6
	neurological comorbidities -- 4
	new comorbidity model -- 3
	comorbid depression -- 3
	comorbidity group -- 3
	comorbid migraine -- 3
84. APPROACH -- score = 2.06445798923
	EXPERIMENTAL APPROACH -- 3
85. rat -- score = 2.06069784035
	rat model -- 25
	migraine rats -- 7
	rats -- 5
	freely-moving rats -- 3
	juvenile rats -- 3
	rat brain -- 3
	DMO rats -- 3
	rat cortex -- 2
	rat retina -- 2
	conscious rats -- 2
86. presentations -- score = 2.06069784035
	clinical presentation -- 6
	clinical presentations -- 3
	CASE PRESENTATION -- 3
	first presentation -- 2
	facial presentations -- 2
	peak presentations -- 1
	consecutive presentations -- 1
	classical presentation -- 1
	vestibular migraines presentation -- 1
	flashlight presentation -- 1
87. general -- score = 2.05307844348
	general population -- 43
	general practice -- 3
	general self-efficacy -- 3
	generalized anxiety disorder-7 -- 3
	attack generation -- 2
	headache generation -- 2
	generic triptans -- 2
	general hypertension -- 2
	general practitioners -- 2
	general agreement -- 1
88. images -- score = 2.05307844348
	magnetic resonance imaging -- 33
	brain magnetic resonance imaging -- 5
	TOF-MRA images -- 3
	brain structural images -- 2
	imaging -- 2
	routine brain imaging -- 2
	diffusion tensor images -- 2
	brain imaging -- 2
	OCTA images -- 2
	perfusion imaging -- 2
89. history -- score = 2.04921802267
	family history -- 23
	medical history -- 13
	migraine history -- 11
	positive family history -- 5
	familial history -- 3
	headache history -- 3
	concussion history -- 3
	case histories -- 2
	patient history -- 2
	positive history -- 2
90. results -- score = 2.04532297879
	inconsistent results -- 4
	treatment results -- 3
	similar results -- 3
	positive results -- 3
	preliminary results -- 3
	clinical results -- 3
	present results -- 2
	VAT results -- 2
	final results -- 2
	results migraine -- 2
91. tension-type -- score = 2.04139268516
	tension-type headache -- 86
	tension-type headaches -- 14
	chronic tension-type headache -- 3
	tension-type headache INTERVENTIONS -- 1
	tension-type headache diagnosis -- 1
	tension-type headache group -- 1
	tension-type headache studies -- 1
	tension-type headaches tricyclic antidepressants -- 1
	tension-type headache patients -- 1
	tension-type headache groups -- 1
92. phase -- score = 2.03342375549
	interictal phase -- 13
	headache phase -- 6
	premonitory phase -- 5
	painful phase -- 4
	preictal phase -- 4
	phase III trials -- 3
	migraine phases -- 3
	ictal phase -- 3
	parallel-group phase -- 2
	different phases -- 2
93. scale -- score = 2.03342375549
	visual analogue scale -- 10
	migraine disability assessment scale -- 5
	depression scale -- 5
	visual analog scale -- 4
	perceived stress scale -- 4
	numeric rating scale -- 2
	epworth sleepiness scale -- 2
	rankin scale -- 2
	behavior scale -- 2
	epworth sleepiness scale score -- 2
94. role -- score = 2.02938377769
	important role -- 18
	key role -- 13
	potential role -- 6
	pivotal role -- 6
	crucial role -- 6
	possible role -- 5
	critical role -- 4
	functional role -- 3
	causative role -- 3
	functional roles -- 3
95. methods -- score = 2.02530586526
	delivery methods -- 3
	pairwise methods -- 2
	willingness-to-pay methods -- 2
	feature selection methods -- 2
	non-invasive methods -- 2
	individual feature selection methods -- 1
	methods data -- 1
	permutation methods -- 1
	analytical methods -- 1
	methods implies -- 1
96. family -- score = 2.02118929907
	family history -- 23
	family caregivers -- 7
	familial factors -- 7
	familial hemiplegic migraine -- 6
	positive family history -- 5
	familial hemiplegic migraine type -- 4
	familial history -- 3
	family approach -- 3
	familial predisposition -- 3
	family GPCR -- 2
97. new -- score = 2.0170333393
	new patients -- 4
	new criteria -- 4
	new approach -- 3
	new comorbidity model -- 3
	new approaches -- 3
	new method -- 2
	new perspective -- 2
	new promising approach -- 2
	new insight -- 2
	new onset -- 2
98. measures -- score = 2.0170333393
	primary outcome measure -- 7
	outcome measures -- 4
	repeated measures -- 4
	MAIN OUTCOME MEASURES -- 3
	secondary outcome measures -- 3
	primary outcome measures -- 2
	preventive measures -- 2
	measurement model -- 2
	MAIN OUTCOME MEASURE -- 2
	baseline measures -- 2
99. period -- score = 2.01283722471
	interictal period -- 12
	wiley periodicals -- 6
	follow-up period -- 6
	attack period -- 4
	study period -- 4
	postpartum period -- 3
	treatment periods -- 2
	6-month period -- 2
	7-year period -- 2
	latency period -- 2
100. researches -- score = 2.01283722471
	vivo researches -- 1
	future researches -- 1
	basic researchers -- 1
	many researchers -- 1
	migraine researchers -- 1
	recent years researchers -- 1
